Zhou Xiaojuan, Yu Min, Zhuo Hongyu, Zhang Shuang
Department of Thoracic Oncology, West China Hospital, Sichuan University Department of Oncology, Shang Jin Nan Fu Hospital Department of Head and Neck Oncology, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
Medicine (Baltimore). 2018 Mar;97(9):e0049. doi: 10.1097/MD.0000000000010049.
Myoepithelial carcinoma mainly occurs in the salivary glands, but myoepithelial carcinoma of the lung is extremely rare neoplasm whose biological behavior and clinical course still remain to be fully elucidated. Although considered as low-grade carcinoma, these tumors have a high rate of recurrence or distant metastasis.
To date there are only 11 cases of pulmonary myoepithelial carcinoma reported in the English literature. We report a case of a 24-year-old woman diagnosed with primary pulmonary myoepithelial carcinoma. Informed consent was obtained from the patient.
The tumor derived from superior lobe of left lung and exhibited only myoepithelial differentiation without any ductal formation by histopathological and immunohistochemical analysis.
The patient underwent the left superior lobe resection. In addition, we first introduce second-generation sequencing technology as a novel strategy for primary pulmonary myoepithelial carcinoma, and these tumors should be included in the differential diagnosis of thoracic neoplasms.
The patient was alive with no evidence of disease for up to 12 months.
Individualized treatment is the promising clinical strategy for thoracic neoplasms, and the underlying molecular events should be investigated to find the potential therapeutic targets.
肌上皮癌主要发生于涎腺,但肺肌上皮癌是一种极其罕见的肿瘤,其生物学行为和临床病程仍有待充分阐明。尽管被认为是低级别癌,但这些肿瘤具有较高的复发率或远处转移率。
迄今为止,英文文献中仅报道了11例肺肌上皮癌病例。我们报告了一例24岁女性被诊断为原发性肺肌上皮癌的病例。已获得患者的知情同意。
通过组织病理学和免疫组化分析,肿瘤起源于左肺上叶,仅表现为肌上皮分化,无任何导管形成。
患者接受了左上叶切除术。此外,我们首次引入二代测序技术作为原发性肺肌上皮癌的一种新策略,并且这些肿瘤应纳入胸段肿瘤的鉴别诊断中。
患者存活,长达12个月无疾病证据。
个体化治疗是胸段肿瘤有前景的临床策略,应研究潜在的分子事件以寻找潜在的治疗靶点。